GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
10 Health Care Stocks With Whale Alerts In Today's Session
What the Options Market Tells Us About Novo Nordisk
Behind the Scenes of Eli Lilly's Latest Options Trends
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Wednesday Ends With Index Decline | Wall Street Today
Wolfe's Short Ideas: Companies With Potential Dividend Cuts